Brazil demands an inside-out strategy
This article was originally published in Clinica
Executive Summary
A couple of recent announcements made by leading health authorities in Brazil may be seen as an invitation to foreign pharmaceutical and medical device companies either to develop and enhance their local businesses, or else to rethink their ability to succeed in this tropical soil.